“Substance+dependence”的搜索结果，显示 301-310 项，共有 3361 项
Currently, most drug-related cancer care is conducted in clinic type centers or hospitals which may isolate patients from family, friends and familiar ...
The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't approved by the U.S. Food and Drug Administration (FDA). However ...
Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...
... abuse potential. A Study of the Ability to Predict Lymphedema Development Following Axillary Surgery for Breast Cancer and Its Effects on Patient ...
... abuse potential. Allogeneic Mesenchymal Stromal Cell Donor Bank. Rochester, Minn. The purpose of this study is to collect adipose tissue from patients ...
Several bispecific antibody therapies have been approved by the U.S. Food and Drug Administration (FDA). Most are used to treat blood cancers and cancers of ...
Other preclincal models to test drug effcicacy includes ex vivo 3D culture and 2D culture systems. In this study, we make and test preclinical models of ...
Transplant, Substance abuse, Depression, Alcohol use disorder, Bipolar disorder, Anxiety disorder. Laura Suarez Pardo, M.D..
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。